[go: up one dir, main page]

MX9704968A - Inhibidores que contienen acido hidroxamico de metaloproteasas de matriz. - Google Patents

Inhibidores que contienen acido hidroxamico de metaloproteasas de matriz.

Info

Publication number
MX9704968A
MX9704968A MX9704968A MX9704968A MX9704968A MX 9704968 A MX9704968 A MX 9704968A MX 9704968 A MX9704968 A MX 9704968A MX 9704968 A MX9704968 A MX 9704968A MX 9704968 A MX9704968 A MX 9704968A
Authority
MX
Mexico
Prior art keywords
compounds
hydroxamic acid
matrix metalloproteases
formula
pharmaceutical compositions
Prior art date
Application number
MX9704968A
Other languages
English (en)
Other versions
MXPA97004968A (es
Inventor
Kenneth Edward Yelm
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX9704968A publication Critical patent/MX9704968A/es
Publication of MXPA97004968A publication Critical patent/MXPA97004968A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invencion provee compuestos que contienen ácido hidroxámico que son utiles como inhibidores de metaloproteasa de matriz y que son efectivos para tratar condiciones asociadas con la actividad en exceso de estas enzimas; en particular, la presente invencion se refiere a un compuesto que tiene una estructura de conformidad con la formula I, en donde: (A) R1, R2, R3, R4 y R5 son independientemente seleccionados a partir de varios substituyentes; y (B) en donde R3 y R4 o R4 y R5 juntos pueden comprender una porcion cíclica; o una sal farmacéuticamente aceptable, amida biohidrolizable o éster biohidrolizable del mismo; en otros aspectos, la invencion está dirigida a composiciones farmacéuticas que contienen los compuestos de la formula (I), y a métodos para tratar enfermedades caracterizadas por la actividad de metaloproteasa de matriz usando estos compuestos o las composiciones farmacéuticas que las contienen.
MXPA/A/1997/004968A 1994-12-29 1997-06-30 Inhibidores que contienen acido hidroxamico de metaloproteasas de matriz MXPA97004968A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/366,062 US5639746A (en) 1994-12-29 1994-12-29 Hydroxamic acid-containing inhibitors of matrix metalloproteases
US08366062 1994-12-29
PCT/US1995/016140 WO1996020918A1 (en) 1994-12-29 1995-12-13 Hydroxamic acid-containing inhibitors of matrix metalloproteases

Publications (2)

Publication Number Publication Date
MX9704968A true MX9704968A (es) 1997-10-31
MXPA97004968A MXPA97004968A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
NO973035L (no) 1997-08-29
NZ298677A (en) 1999-03-29
KR980700963A (ko) 1998-04-30
BR9510175A (pt) 1997-10-14
EP0800510A1 (en) 1997-10-15
CA2208679A1 (en) 1996-07-11
US5639746A (en) 1997-06-17
NO973035D0 (no) 1997-06-27
CN1171780A (zh) 1998-01-28
AU706409B2 (en) 1999-06-17
AU4422096A (en) 1996-07-24
JPH10512241A (ja) 1998-11-24
WO1996020918A1 (en) 1996-07-11

Similar Documents

Publication Publication Date Title
CA2264254A1 (en) Phosphinic acid amides as matrix metalloprotease inhibitors
IL128666A (en) Substituted cyclic amine metalloprotease inhibitors
MX9701893A (es) Nuevos inhibidores de la prostaglandinsintasa.
YU20199A (sh) Heterociklični sukcinimidi i njihova primena kao metaloproteinaznih inhibitora
NO950849L (no) Derivater av valproin og 2-valproensyreamider og anvendelse som antikonvulsanter
DE69711391D1 (de) Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern
NO973035L (no) Hydroksaminsyre-holdige inhibitorer for matriks-metallproteaser
DK165003C (da) Chlorsulfat
EA200100867A1 (ru) Сульфаматогидроксамовая кислота как ингибитор металлопротеаз
CA1273019C (en) ENKEPHALINASE INHIBITORS
NO990896L (no) Bidentate metalloproteaseinhibitorer
HK1044754A1 (zh) 含有烯烃基-和烯烃金属蛋白酶抑制剂
MXPA03000547A (es) Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares.
WO2001070720A3 (en) Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
PL317349A1 (en) Organic compounds
WO2001070693A3 (en) Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
AP2000002001A0 (en) Hydroxamic acid derivatives as inhibitors of the production of human CD23 and of the tnf relaease.
MX9707214A (es) Derivados de acido hidroxamico que contiene lactama, composiciones que contienen los mismos y el uso de los mismos.
GEP20032923B (en) Sulphonamide Derivatives as Prodrugs of Aspartyl Protease Inhibitors, Pharmaceutical compositions containing the Same and Methods for Treatment